Rudy Schreiber – New VP of Translational Research and Development

GliaCure is pleased to announce that Dr. Rudy Schreiber has joined the team as Vice President of Translational Research and Development. Dr. Schreiber previously held positions at Roche, Sepracor and Evotec, where he developed expertise and leadership in behavioral studies with a specific focus on CNS projects. His experience as a scientist and as a project and team leader in various pharma groups allows him to provide invaluable support to GliaCure’s development program.